OJGas  Vol.2 No.3 , August 2012
Suggested guidelines for the diagnosis and management of chronic HCV infection in children
ABSTRACT
HCV infection in children is different from the adult infection in many ways like natural course of the disease; duration, therapeutic response and side effects profile of the drug therapy; and prognosis. Special considerations include what is the appropriate time to investigate a suspected child, when to institute and choice of drug therapy and how to prevent vertical transmission. In this article, based on the current evidence suggested guidelines for the diagnosis and management of chronic HCV infection in children is given. Feedback to help improve/modify these recommendations by those experienced in dealing with the children will be welcome.

Cite this paper
Danish, F. (2012) Suggested guidelines for the diagnosis and management of chronic HCV infection in children. Open Journal of Gastroenterology, 2, 131-142. doi: 10.4236/ojgas.2012.23027.
References
[1]   Hamid, S., Umar, M., Alam, A., Siddiqui, A., Qureshi, H., Butt, J., et al. (2004) PSG consensus statement on the management of hepatitis C virus nfection-2003. Journal of the Pakistan Medical Association, 54, 146-150.

[2]   Alter, M.J. (1997) Epidemiology of hepatitis C. Hepatology, 26, 62S. doi:10.1002/hep.510260711

[3]   Jonas, M.M. (2002) Children with hepatitis C. Hepatology, 36, S173-S178. doi:10.1002/hep.1840360722

[4]   Davison, S.M. and Kelly, D.A. (2008) Management strategies for hepatitis C virus infection in children. Pediatric Drugs, 10, 357-365. doi:10.2165/0148581-200810060-00003

[5]   Yeung, L.T., King, S.M. and Roberts, E.A. (2001) Mother-to-infant transmission of hepatitis C virus. Hepatology, 34, 223. doi:10.1053/jhep.2001.25885

[6]   Bortolotti, F., Resti, M., Giacchino, R., Crivellaro, C., Zancan, L., Azzari, C., et al. (1998) Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. Journal of Pediatrics, 133, 378-381. doi:10.1016/S0022-3476(98)70273-2

[7]   Nelson, S.P. and Jonas, M.M. (1996) Hepatitis C infection in children who received extracorporeal membrane oxygenation. Journal of Pediatric Surgery, 31, 644. doi:10.1016/S0022-3468(96)90665-X

[8]   Ni, Y.H., Chang, M.H., Lue, H.C., et al. (1994) Posttransfusion hepatitis C virus infection in children. Journal of Pediatrics, 124, 709. doi:10.1016/S0022-3476(05)81359-9

[9]   Bortolotti, F., Verucchi, G., Cammà, C., Cabibbo, G., Zancan, L., Indolfi, G., et al. (2008) Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology, 13, 1900-1907. doi:10.1053/j.gastro.2008.02.082

[10]   Hsu, S.C., Chang, M.H., Chen, D.S., Hsu, H.C. and Lee, C.Y. (1991) Non-A, non-B hepatitis in children: a clinical, histologic, and serologic study. Journal of Medical Virology, 35, 1-6. doi:10.1002/jmv.1890350102

[11]   Bortolotti, F., Vajro, P., Cadrobbi, P., Lepore, L., Zancan, L., Barbera, C., et al. (1992) Cryptogenic chronic liver disease and hepatitis C virus infection in children. Journal of Hepatology, 15, 73-76. doi:10.1016/0168-8278(92)90014-G

[12]   Tovo, P.A., Pembrey, L.J. and Newell, M.L. (2000) Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. Journal of Infectious Diseases, 181, 419.

[13]   Gholson, C.F., Morgan, K., Catinis, G., Favrot, D., Taylor, B., Gonzalez, E. and Balart, L. (1997) Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. The American Journal of Gastroenterology, 92, 1788-1792.

[14]   Martinot-Peignoux, M., Boyer, N., Cazals-Hatem, D., Pham, B.N., Gervais, A., Le Breton, V., Levy, S., et al. (2001) Prospective study on anti-hepatitis C virus positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology, 34, 1000-1005. doi:10.1053/jhep.2001.28458

[15]   Pradat, P., Alberti, A., Poynard, T., Esteban, J.I., Weiland, O., Marcellin, P., Badalamenti, S., et al. (2002) Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study. Hepatology, 36, 973-977.

[16]   Bortolotti, F., Jara, P., Diaz, C., Vajro, P., Hierro, L., Giacchino, R., et al. (1994) Post transfusion and community-acquired hepatitis C in childhood. Journal of Pediatric Gastroenterology and Nutrition, 18, 279-283. doi:10.1097/00005176-199404000-00005

[17]   Casiraghi, M.A., De Paschale, M., Romanò, L., et al. (2004) Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology, 39, 90. doi:10.1002/hep.20030

[18]   Bortolotti, F., Resti, M., Giacchino, R., Azzari, C., Gussetti, N., Crivellaro, C., et al. (1997) Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. Journal of Pediatrics, 130, 990-993. doi:10.1016/S0022-3476(97)70289-0

[19]   Kage, M., Fujisawa, T., Shiraki, K., Tanaka, T., Kimura, A., Shimamatsu, K., et al. (1997) Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology, 26, 771-775. doi:10.1002/hep.510260333

[20]   Badizadegan, K., Jonas, M.M., Ott, M.J., Nelson, S.P. and Perez-Atayde, A.R. (1998) Histopathology of the liver in children with chronic hepatitis C viral infection. Hepatology, 28, 1416-1423. doi:10.1002/hep.510280534

[21]   Guido, M., Rugge, M., Jara, P., Hierro, L., Giacchino, R., Larrauri, J., et al. (1998) Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology, 115, 1525-1529. doi:10.1016/S0016-5085(98)70032-0

[22]   European Paediatric Hepatitis C Virus Network. (2005) Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clinical Infectious Diseases, 41, 45. doi:10.1086/430601

[23]   Jonas, M.M., Baron, M.J., Bresee, J.S. and Schneider, L.C. (1996) Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics, 98, 211.

[24]   Kuroki, T., Nishiguchi, S., Fukuda, K., et al. (1993) Vertical transmission of hepatitis C virus (HCV) detected by HCV-RNA analysis. Gut, 34, S52. doi:10.1136/gut.34.2_Suppl.S52

[25]   Matsubara, T., Sumazaki, R. and Takita, H. (1995) Mother-to-infant transmission of hepatitis C virus: A prospective study. European Journal of Pediatrics, 154, 973. doi:10.1007/BF01958640

[26]   Sabatino, G., Ramenghi, L.A., di Marzio, M. and Pizzigallo, E. (1996) Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. European Journal of Epidemiology, 12, 443. doi:10.1007/BF00143994

[27]   Mazza, C., Ravaggi, A., Rodella, A., et al. (1998) Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection. Study Group for Vertical Transmission. Journal of Medical Virology, 54, 12. doi:10.1002/(SICI)1096-9071(199801)54:1<12::AID-JMV3>3.0.CO;2-S

[28]   Giacchino, R., Tasso, L., Timitilli, A., et al. (1998) Vertical transmission of hepatitis C virus infection: usefulness of viremia detection in HIV-seronegative hepatitis C virus-seropositive mothers. Journal of Pediatrics, 132, 167. doi:10.1016/S0022-3476(98)70507-4

[29]   Manzini, P., Saracco, G., Cerchier, A., et al. (1995) Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission) persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology, 21, 328. doi:10.1016/0270-9139(95)90088-8

[30]   Paccagnini, S., Principi, N., Massironi, E., et al. (1995) Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. The Pediatric Infectious Disease Journal, 14, 195. doi:10.1097/00006454-199503000-00005

[31]   Sherman, M., Shafran, S., Burak, K., Doucette, K., Wong, W., Girgrah, N., et al. (2007) Management of chronic hepatitis C: Consensus guidelines. Canadian Journal of Gastroenterology, 21, 25C-34C.

[32]   Fazal, A.D. (2008) Current Standards in the Pharmacotherapy of Chronic Hepatitis C and Local Practices. Infectious Diseases Journal, 17, 93-7.

[33]   Conte, D., Fraquelli, M., Prati, D., et al. (2000) Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology, 31, 751. doi:10.1002/hep.510310328

[34]   England, K., Pembrey, L., Tovo, P.A., Newell, M.L., European Paediatric HCV Network. (2005) Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers. Acta Paediatrica, 94, 444. doi:10.1111/j.1651-2227.2005.tb01916.x

[35]   American Academy of Pediatrics, Committee on Infectious Diseases (1997) 1997 Red book: Report of the committee on infectious diseases. 24th Edition, American Academy of Pediatrics, Elk Grove Village, 263.

[36]   Cagle, H.H., Jacob, J., Homan, C.E., et al. (2007) Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992. Archives of Pediatrics & Adolescent Medicine, 161, 125. doi:10.1001/archpedi.161.2.125

[37]   Jonas, M.M. (2007) Finding adolescents and young adults with transfusion-associated hepatitis C: looking forward to looking back. Archives of Pediatrics & Adolescent Medicine, 161, 202. doi:10.1001/archpedi.161.2.202

[38]   Goodman, Z.D, Makhlouf, H.R., Liu, L., et al. (2008) Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial. Hepatology, 47, 836. doi:10.1002/hep.22094

[39]   Bedossa, P. and Poynard T. (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 24, 289-293. doi:10.1002/hep.510240201

[40]   Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., et al. (1995) Histological grading and staging of chronic hepatitis. Journal of Hepatology, 22, 696-699. doi:10.1016/0168-8278(95)80226-6

[41]   Marcellin, P., Asselah, T. and Boyer, N. (2002) Fibrosis and disease progression in hepatitis C. Hepatology, 36, S47-S56. doi:10.1002/hep.1840360707

[42]   Strader, D.B., Wright, T., Thomas, D.L. and Seeff, L.B. (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology, 39, 1147-71. doi:10.1002/hep.20119

[43]   Gonzalez-Peralta, R., Haber, B.A., Jonas, M., Martin, S., Lang, T., Geffner, M., et al. (2002) Interferon-alfa 2b in combination with ribavirin for the treatment of chronic hepatitis C in children [Abstract]. Hepatology, 36, 311A.

[44]   González-Peralta, R.P., Kelly, D.A., Haber, B., Molleston, J., Murray, K.F., Jonas, M.M., et al. (2005) International Pediatric Hepatitis C Therapy Group. Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics. Hepatology, 42, 1010-1018.

[45]   Jacobsen, I.M., Ahmed, F., Russo, M.W., Brown, R.S., Lebovics, E., Min, A., et al. (2003) Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: a trial in non-responders to interferon monotherapy or combination therapy and in combination therapy relapsers: final results. Gastroenterology, 124, A540.

[46]   Palumbo, E. (2009) Treatment for Chronic Hepatitis C in Children: A Review. American Journal of Therapeutics, 16, 446-450. doi:10.1097/MJT.0b013e31818a88c5

[47]   Ghany, M.G., Strader, D.B., Thomas, D.L. and Seeff, L.B., (2009) American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology, 49, 1335. doi:10.1002/hep.22759

[48]   Wirth, S., Ribes-Koninckx, C., Calzado, M.A., et al. (2010) High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. Journal of Hepatology, 52, 501. doi:10.1016/j.jhep.2010.01.016

[49]   Jara, P., Hierro, L., de la Vega, A., Díaz, C., Camarena, C., Frauca, E., et al. (2008) Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection. The Pediatric Infectious Disease Journal, 27, 142-148.

[50]   Schwarz, K.B., Gonzalez-Peralta, R.P., Murray, K.F., et al. (2008) Peginterferon with or without ribavirin for chronic hepatitis C in children and adolescents: final results of the PEDS-C trial. Hepatology, 48, 418A.

[51]   Fazal, A.D., Salman, S.K., Fazal, R.S., Ahmed, E.R. and Saeeda, Y. (2009) Diagnosis and treatment of HCV infection in children: Suggested recommendations for the development of local guidelines. Journal of Pakistan Paediatric Association, 33, 203-210

[52]   Danish, F.A., Koul, S.S., Subhani, F.R., Rabbani, A.E. and Yasmin, S. (2010) Managing HCV infection in paediatric age group: Suggested recommendations. Saudi Journal of Gastroenterology, 16, 230-235. doi:10.4103/1319-3767.65182

[53]   Comanor, L., Minor, J., Conjeevaram, H.S., Roberts, E.A., Alvarez, F., Bern, E.M., et al. (2001) Impact of chronic hepatitis B and interferon-alpha therapy on growth of children. Journal of Viral Hepatitis, 8, 139-147. doi:10.1046/j.1365-2893.2001.00262.x

[54]   Gottrand, F., Michaud, L., Guimber, D., Ategbo, S., Dubar, G., Turck, D., et al. (1996) Influence of recombinant interferon alpha on nutritional 1168 STRADER ET AL. HEPATOLOGY, April 2004 status and growth pattern in children with chronic viral hepatitis. European Journal of Pediatrics, 155, 1031-1034. doi:10.1007/BF02532525

[55]   (2009) Prescribing Information for PegIntron? package Insert. Drugs@FDA.gov

[56]   Delgado-Borrego, A., Healey, D., Negre, B., et al. (2010) Influence of body mass index on outcome of paediatric chronic hepatitis C virus infection. Journal of Pediatric Gastroenterology and Nutrition, 51, 191. doi:10.1097/MPG.0b013e3181d32756

[57]   Bunn, S., Kelly, D., Murray, K.F., Shelton, M., Olson, A., Mieli-Vergani, G., et al. (2000) Safety, efficacy and pharmacokinetics of interferonalfa-2b and ribavirin in children with chronic hepatitis C [Abstract]. Hepatology, 32, 350A.

[58]   Maddrey, W.C. (1999) Safety of combination interferon alfa-2b/RBV therapy in chronic hepatitis C-relapsed and treatment-naive patients. Seminars in Liver Disease, 19, 67-75.

[59]   Mirza, R., Memon, I., Cheema, H.U., Ali, S., Thobani, S. and Shah, U. (2007) Recommendations for the treatment of chronic Hepatitis C infection in children. Journal Pakistan Medical Association, 57, 419-420

[60]   Danish, F.A., Koul, S.S., Subhani, F.R., Rabbani, A.E. and Yasmin, S. (2008) Role of haematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients. Saudi Journal of Gastroenterology, 14, 151-157. doi:10.4103/1319-3767.41739

[61]   Iacobellis, A., Siciliano, M., Perri, F., Annicchiarico, B.E., Leandro, G., Caruso, N., et al. (2007) Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study. Journal of Hepatology, 46, 206-212. doi:10.1016/j.jhep.2006.08.020

[62]   Tekin, F., Gunsar, F., Karasu, Z., Akarca, U. and Ersoz, G. (2008) Safety, tolerability, and efficacy of pegylated-interferon alfa-2a plus ribavirin in HCV-related decompensated cirrhotics. Alimentary Pharmacology & Therapeutics, 27, 1081-1085. doi:10.1111/j.1365-2036.2008.03680.x

[63]   Danish, F.A., Koul, S.S., Subhani, F.R., Rabbani, A.E. and Yasmin, S. (2010) Antiviral therapy in HCV-infected decompensated cirrhotics. Saudi Journal of Gastroenterology, 16, 310-314. doi:10.4103/1319-3767.70632

[64]   Danish, F.A., Koul, S.S., Subhani, F.R., Rabbani, A.E. and Yasmin, S. (2010) Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag. Saudi Journal of Gastroenterology, 16, 51-6. doi:10.4103/1319-3767.58772

[65]   Thomas, S.L., Newell, M.L., Peckham, C.S., et al. (1998) A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. International Journal of Epidemiology, 27, 108. doi:10.1093/ije/27.1.108

[66]   Zanetti, A.R., Tanzi, E., Romanò, L., et al. (1998) A prospective study on mother-to-infant transmission of hepatitis C virus. Intervirology, 41, 208. doi:10.1159/000024938

[67]   Terrault, N. (1998) Epidemiological evidence for perinatal transmission of hepatitis C virus. Viral Hepatitis Reviews, 4, 245.

[68]   Moriya, T., Sasaki, F., Mizui, M., et al. (1995) Transmission of hepatitis C virus from mothers to infants: its frequency and risk factors revisited. Biomedicine & Pharmacotherapy, 49, 59. doi:10.1016/0753-3322(96)82587-X

[69]   Azzari, C., Resti, M., Moriondo, M., et al. (2000) Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood, 96, 2045.

[70]   Mast, E.E., Hwang, L.Y., Seto, D.S., et al. (2005) Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. Journal of Infectious Diseases, 192, 1880. doi:10.1086/497701

[71]   Centers for Disease Control and Prevention (1998) Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report, 47, 1-39.

[72]   Mast, E.E. and Alter, M.J. (1997) Hepatitis C. Seminars in Pediatric Infectious Diseases, 8, 17-22. doi:10.1016/S1045-1870(97)80005-2

[73]   McIntyre, P.G., Tosh, K. and McGuire, W. (2006) Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database of Systematic Reviews, 18, Article ID: CD005546.

[74]   ACOG Committee Opinion (1999) Breastfeeding and the risk of hepatitis C virus transmission. Number 220, August 1999. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. International Journal of Gynecology & Obstetrics, 66, 307.

[75]   Zanetti, A.R., Tanzi, E., Paccagnini, S., et al. (1995) Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet, 345, 289. doi:10.1016/S0140-6736(95)90277-5

[76]   Lin, H.H., Kao, J.H., Hsu, H.Y., et al. (1995) Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. Journal of Pediatrics, 126, 589. doi:10.1016/S0022-3476(95)70356-X

[77]   Polywka, S., Schr?ter, M., Feucht, H.H., et al. (1999) Low risk of vertical transmission of hepatitis C virus by breast milk. Clinical Infectious Diseases, 29, 1327. doi:10.1086/313473

[78]   Kumar, R.M. and Shahul, S. (1998) Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. Journal of Hepatology, 29, 191. doi:10.1016/S0168-8278(98)80003-2

[79]   American Academy of Pediatrics, Committee on Infectious Diseases (2009) Hepatitis C. In: Pickering, L.K., Ed., Red Book: 2009 Report of the Committee on Infectious Diseases, 28th Edition, American Academy of Pediatrics, Elk Grove Village, 357.

[80]   Fontaine, H., Nalpas, B., Carnot, F., et al. (2000) Effect of pregnancy on chronic hepatitis C: a case-control study. Lancet, 356, 1328. doi:10.1016/S0140-6736(00)02823-3

[81]   Di Martino, V., Lebray, P., Myers, R.P., et al. (2004) Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology, 40, 1426. doi:10.1002/hep.20463

[82]   Vegnente, A., Iorio, R., Saviano, A., et al. (1994) Lack of intrafamilial transmission of hepatitis C virus in family members of children with chronic hepatitis c infection. The Pediatric Infectious Disease Journal, 13, 886-889.

[83]   Suzuki, T., Omata, K., Satoh, T., et al. (2005) Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients. Journal of Clinical Microbiology, 43, 4413-4417.

[84]   Buti, M., Valdes, A., Sanchez-Avila, F., Esteban, R. and Lurie, Y. (2003) Extending combination therapy with peginterferon-alpha-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: A report of 9 cases. Hepatology, 37, 1226-1227. doi:10.1053/jhep.2003.50107

[85]   Berg, T., von Wegner, M., Nasser, S., et al. (2006) Extended treatment duration for hepatitis C virus type 1: Comparing 48 versus 72 of peginterferon-alpha-2a plus ribavirin. Gastroenterology, 130, 1086-1097. doi:10.1053/j.gastro.2006.02.015

[86]   Ferencie, P., Lafen, H., Scherzer, T.M., et al. (2006) Customizing treatment with peginterferon-alpha-2A (40KD) (Pegasys[R]) plus ribavirin in patients with HCV genotype 1 or 4 infection. Hepatology, 44, 336A. (Abstract 390).

 
 
Top